GlassScriptPhysician profile
Nikhil Waingankar
NPI 1316119233
$17,705.74
in general payments reported to CMS, 2019-2025
11 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,590 · 2020: $3,022 · 2021: $3,383 · 2022: $1,191 · 2023: $209 · 2024: $27.99 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $9,531.08 | 2019-2022 | |
| Pfizer INC. | $6,220.44 | 2020-2022 | |
| Boston Scientific Corporation | $1,097.23 | 2019-2023 | |
| Ferring Pharmaceuticals INC. | $218.90 | 2019-2025 | Adstiladrin |
| Intuitive Surgical, INC. | $216.57 | 2019 | |
| Karl Storz Endoscopy-America | $130.78 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2020 | |
| Urogen Pharma, INC. | $90.73 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $38.04 | 2022 | |
| Telix Pharmaceuticals | $19.52 | 2025 | Illuccix |
| Laborie Medical Technologies Corp. | $17.45 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikhil Waingankar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.